Pipeline | 2021 | 2022 | 2023 | 2024 | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1Q | 2Q | 3Q | 4Q | 1Q | 2Q | 3Q | 4Q | 1Q | 2Q | 3Q | 4Q | 1Q | 2Q | 3Q | 4Q | |
AZBF11509 |
Target analysis In vitro In vivo Pre-clinical |
|||||||||||||||
License out |
||||||||||||||||
AZBT12128 |
Target analysis In vitro In vivo Pre-clinical |
|||||||||||||||
License out |
- From Hit Discovery to Lead Optimization